DROR has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
DROR has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Dror Ortho-Design's change in receivables for the quarter that ended in Mar. 2024 was $0.01 Mil. It means Dror Ortho-Design's Accounts Receivable declined by $0.01 Mil from Dec. 2023 to Mar. 2024 .
Dror Ortho-Design's change in receivables for the fiscal year that ended in Dec. 2023 was $-0.01 Mil. It means Dror Ortho-Design's Accounts Receivable increased by $0.01 Mil from Dec. 2022 to Dec. 2023 .
Dror Ortho-Design's Accounts Receivable for the quarter that ended in Mar. 2024 was $0.00 Mil.
Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Dror Ortho-Design's liquidation value for the three months ended in Mar. 2024 was $2.27 Mil.
The historical data trend for Dror Ortho-Design's Change In Receivables can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dror Ortho-Design Annual Data | |||||||||||||||||||||
Trend | Dec05 | Dec06 | Dec07 | Dec08 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
Change In Receivables | Get a 7-Day Free Trial | - | - | - | -0.07 | -0.01 |
Dror Ortho-Design Quarterly Data | ||||||||||||||||||||
Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | |
Change In Receivables | Get a 7-Day Free Trial | -0.05 | 0.05 | -0.04 | 0.03 | 0.01 |
Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.
Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.05 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dror Ortho-Design (OTCPK:DROR) Change In Receivables Explanation
1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
Dror Ortho-Design's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:
Days Sales Outstanding | |||||
= | Accounts Receivable | / | Revenue | * | Days in Period |
= | 0 | / | 0 | * | 91 |
= |
2. In Ben Graham's calculation of liquidation value, Dror Ortho-Design's accounts receivable are only considered to be worth 75% of book value:
Dror Ortho-Design's liquidation value for the quarter that ended in Mar. 2024 is calculated as:
Liquidation Value | |||||||
= | Cash, Cash Equivalents, Marketable Securities | - | Total Liabilities | + | (0.75 * Accounts Receivable) | + | (0.5 * Total Inventories) |
= | 2.55 | - | 0.283 | + | 0.75 * 0 | + | 0.5 * 0 |
= | 2.27 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of Dror Ortho-Design's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.
Eliyahu Haddad | director, officer: Chief Executive Officer | SHATNER STREET 3, JERUSALEM L3 NA |
Chaim Ravad | director | SHATNER STREET 3, JERUSALEM L3 NA |
Yehuda Englander | director | SHATNER STREET 3, JERUSALEM L3 NA |
Moshe Shvets | director, officer: Chief Technology Officer | SHATNER STREET 3, JERUSALEM L3 NA |
Chaim Hurvitz | director | C/O GALMED PHARMACEUTICALS LTD., 8 SHAUL, HAMELECH BLVD, AMOT HAMISHPAT BLDG., TEL AVIV L3 64733 |
Orin Hirschman | director, officer: Chief Executive Officer | 101 EAST 52ND ST, NEW YORK NY 10022 |
Ryan Christoff | director | 480 JOHNSON ROAD SUITE 303, WASHINGTON PA 15301 |
Congregation Ahavas Tzdokah Vchesed Inc. | 10 percent owner, other: See Explanation of Responses | 1347 42ND STREET, BROOKLYN NY 11219 |
Ellis International L.p. | other: See Explanation of Responses | 100 MERRICK ROAD, SUITE 400W, ROCKVILLE CENTRE NY 11570 |
Brian W Long | director | 1010 OHIO RIVER BLVD., PITTSBURGH PA 15202 |
Shannon Lee Vissman | director, 10 percent owner | 1241 TURNBERRY DRIVE, UPPER ST. CLAIR PA 15241 |
Jan K Richardson | director | 1821 HILLANDALE RD., SUITE 307, DURHAM NC 27705 |
Aigh Investment Partners, Llc | 10 percent owner | 6006 BERKELEY AVENUE, BALTIMORE MD 21209 |
V Gerald Grafe | director | 901 RIO GRANDE BOULEVARD NW, BUILDING H, SUITE 262, ALBUQUERQUE NM 87104 |
Walter A Aviles | 10 percent owner, officer: Chief Technical Officer | 9620 SAN MATEO BOULEVARD NE, ALBUQUERQUE NM 87113 |
From GuruFocus
By ACCESSWIRE • 01-08-2024
By ACCESSWIRE • 08-21-2023
By ACCESSWIRE • 09-19-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.